AGP Executive Report
Last update: 6 hours agoEbola Vaccine Rollout: DRC expanded Ebola vaccination to Ituri, launching the BRAVO study in Bunia with MSF and partners; about 3,700 people have already received Ervebo, and roughly 20,000 frontline workers in Ituri and North Kivu will be followed to test whether the Zaire-based vaccine can protect against the Bundibugyo strain. Ebola Response Gaps: WHO reported uneven progress across provinces, with Ituri and Haut Uele seeing declines while North Kivu rose sharply, and warned many infections are only detected after people die outside treatment centers. Mpox Lab Accuracy: Swiss-led research in The Lancet Infectious Diseases found nearly 35% of PCR-positive mpox results in several DRC cities may reflect contamination rather than real infections, raising the risk of false diagnoses and misdirected surveillance. AI in Mining: US firm KoBold Metals is using AI-guided exploration in the DRC to find critical minerals like lithium, aiming to reduce reliance on China’s dominance in copper and cobalt. Digital Influence Watch: Anthropic says actors used Claude AI to generate pro-government narratives via fake news sites focused on DRC-Rwanda tensions and mineral deals. Local Innovation: In South Kivu, young entrepreneurs are building a domestic coffee market in Bukavu, helping farmers sell locally as conflict disrupts exports.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
